ENDOVASTEC
Endovastec specializes in the manufacturing and sales of interventional medical devices. Endovastec’s main products consist of aortic stent grafts for endovascular treatment of thoracic and abdominal aortic diseases, surgical stent grafts applied in combination with open surgery for the treatment of complicated thoracic diseases, aortic balloon dilation catheters, and peripheral vascular stents and balloons. The company operates with a strict quality management system and is equipped with high-precision testing equipment and modern laboratory and clean rooms that meet the national standards for manufacturing Class III implantable products. Endovastec was founded in 2012 and is headquartered in Shanghai, China.
ENDOVASTEC
Industry:
Health Care Manufacturing Medical Device
Founded:
2012-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.endovastec.com
Status:
Active
Contact:
(86) (21) 38139300
Email Addresses:
[email protected]
Technology used in webpage:
Euro Microsoft Exchange Online Pound Sterling Japanese Yen Baidu Maps
Similar Organizations
MicroPort Access Medtech
MicroPort Access Medtech specializes in the research and development of interventional accessory products.
Official Site Inspections
http://www.endovastec.com Semrush global rank: 7.3 M Semrush visits lastest month: 534
- Host name: 121.40.204.186
- IP address: 121.40.204.186
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Endovastec"
About us-Trustworthy and universal access to state-of-the-art total ...
About us,Endovastec™ is committed to provide trustworthy and universal access to state-of-the-art solutions of prolonging and reshaping all lives, and to build a people centric enterprise …See details»
Endovastec-Trustworthy and universal access to state-of-the-art …
Endovastec™ Completes Acquisition of European Medical Device Company Optimum Medical On August 26, 2024, Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (hereinafter …See details»
Endovastec - Crunchbase Company Profile & Funding
Endovastec specializes in the manufacturing and sales of interventional medical devices. Endovastec’s main products consist of aortic stent grafts for endovascular treatment of …See details»
关于我们-血液循环疾病真善美全医疗方案-心脉医疗
心脉医疗™专注于主动脉及外周血管介入医疗器械的研发、生产、销售和服务，拥有5家子公司，包括蓝脉医疗™（主营外周静脉业务）、鸿脉医疗™（主营外周动脉业务）、拓脉医疗™（ …See details»
Endovascular Solutions | Advanced Vascular Devices | MicroPort
Incorporated in Shanghai's International Medical Zone in 2012, Endovastec™ swiftly emerged as a dynamic player in the medical device field. Our dedication to developing total solutions to …See details»
688016 | SHANGHAI STOCK EXCHANGE - s se
Aug 17, 2012 With its 5 self-developed products have been approved by the national "Special Approval Procedure of Innovative Medical Device", Endovastec is staying ahead in the field. …See details»
MicroPort Endovastec. - Company Profile & Staff Directory
Shanghai MicroPort Endovascular MedTech（Group） Co., Ltd. (“Endovastec™”), is a subsidiary of MicroPort Scientific Corporation (\\\"MicroPort®\\\"). Dedicated to global healthcare industry, …See details»
Board of Directors-Endovastec
Board of Directors,Endovastec™ is committed to provide trustworthy and universal access to state-of-the-art solutions of prolonging and reshaping all lives, and to build a people centric …See details»
Endovastec Company Profile 2024: Stock Performance & Earnings
What industry is Endovastec in? Endovastec’s primary industry is Diagnostic Equipment. Is Endovastec a private or public company? Endovastec is a Public company. What is …See details»
MicroPort® Endovastec's™ Castor™ & Hercules™ LP Stent Graft …
Oct 30, 2023 About Endovastec ™ Founded in 2012, Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (Endovastec™; SSE: 688016), an associated company of …See details»
Endovastec Receives MDSAP Certificate | News | MicroPort
Apr 11, 2022 Endovastec™ was listed on the STAR Market (Stock code: 688016) of the Shanghai Stock Exchange on July 22, 2019. Endovastec™ is committed to provide trustworthy …See details»
Company News-Endovastec
Mar 27, 2024 Endovastec™ Completes Acquisition of European Medical Device Company Optimum Medical. 26 Aug 2024 On August 26, 2024, Shanghai MicroPort Endovascular …See details»
Endovastec™ Receives HSA Approval for Minos™ Stent-Graft System
This is Endovastec™’s second product to be approved and launched in Singapore, following the Hercules TM Thoracic Stent Graft with Low Profile Delivery System. The Minos TM Stent-Graft …See details»
Endovastec Stent grafts - All the products on MedicalExpo
Diameter: 14, 12, 10, 8, 6 mm Length: 45, 40, 35, 30, 25 mm. Castor™ Branched Aortic Stent-Graft and Delivery System is the world's first stent graft that can simultaneously repair the …See details»
Hercules LP Stent Graft Implant Completion | News | MicroPort
Mar 6, 2022 Independently developed by Endovastec™, the Hercules ®-LP Stent Graft System was approved for registration by the Central Drugs Standard Control Organization (CDSCO) in …See details»
endovastec-lm.com
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.See details»
Endovastec™ Announces Annual Results for 20212022-Endovastec
Endovastec™ Announces Annual Results for 2021,2022,Endovastec™ is committed to provide trustworthy and universal access to state-of-the-art solutions of prolonging and reshaping all …See details»
心脉门户 - portal.endovastec.com
请启用 JavaScript 以正常使用 Saber。See details»
Governance Structure-Endovastec
Governance Structure,Endovastec™ is committed to provide trustworthy and universal access to state-of-the-art solutions of prolonging and reshaping all lives, and to build a people centric …See details»
Senior Management-Endovastec
Senior Management,Endovastec™ is committed to provide trustworthy and universal access to state-of-the-art solutions of prolonging and reshaping all lives, and to build a people centric …See details»